Medicine and Dentistry
Arm
100%
Randomized Controlled Trial
100%
Central Retinal Vein Occlusion
100%
Macular Edema
100%
Best Corrected Visual Acuity
35%
Therapeutic Procedure
28%
Cost-Effectiveness Analysis
28%
Health Care Cost
21%
Post-Hoc Analysis
21%
Vision
21%
Intention-to-Treat Analysis
21%
Visual Acuity
21%
Patient
21%
Quality Adjusted Life Year
14%
Injection
14%
Visual Impairment
7%
Ophthalmology
7%
Feedback System
7%
Health Care
7%
Combination Therapy
7%
Intravitreal Administration
7%
Noninferiority Trial
7%
Neuroscience
Central Retinal Vein
100%
Retinal Vein Occlusion
100%
Bevacizumab
100%
Ranibizumab
100%
Intention
21%
Ophthalmology
7%
Food Science
Plum
100%
Nutrient
100%
Short Chain Fatty Acid
42%
Bioactive Compound
40%
Starch
20%
Real-Time Polymerase Chain Reaction
14%